LOCAL
| Filename | Size |
|---|---|
 Intergroup-2-vs-4-cm-for-1-4-mm-Ann-Surg-Oncol-2001 |
70.3 KB |
| Swedish-2-vs-5-cm-for-0.8-2-mm-Cancer-2000 |
88.08 KB |
| WHO-1-vs-3-cm-for-0-2-mm-Sem-Surg-Oncol-1998 |
42.06 KB |
NODAL STAGING
| Filename | Size |
|---|---|
| ACOSOG-Z0020-JCO-2006-ILP-Melphalan-wwo-TNF |
243.89 KB |
| MSLT-1-NEJM-2006 |
287.4 KB |
| MSLT-2-NEJM-2017 |
526.11 KB |
| SSO-ASCO-Melanoma-SLNB-guidelines_JCO2012 |
109.58 KB |
| WHO-Lancet-1998---ELND |
286.36 KB |
ADJUVANT TREATMENT
| Filename | Size |
|---|---|
| Adjuvant-high-dose-IFNa-2b-Clin-Canc-Res-2004 |
297.18 KB |
| Adjuvant-high-dose-ipilimumab-NEMJ-2016 |
315.59 KB |
| Adjuvant-nodal-XRT-melanoma-Aussie-2012 |
290.92 KB |
| EORTC-18991-Pegylated-IFNa-2b |
235.82 KB |
METASTATIC
| Filename | Size |
|---|---|
| BRAF-MEK-inhibitor-BRAF-mutant-metastatic-melanoma-NEJM-2014 |
524.02 KB |
| IL-2-Metastatic-Melanoma-JCO-1999 |
189.4 KB |
| Ipilimumab-Metastatic-Melanoma-NEJM-2011 |
658.97 KB |
| Nivolumab-and-ipilimumab-metastatic-melanoma-NEJM-2015 |
435.19 KB |
| Vemurafenib-Metastatic-Melanoma-NEJM-2011 |
608.93 KB |
| Vemurafenib-Refractory-Melanoma-NEJM-2012 |
561.42 KB |
REGIONAL DISEASE
| Filename | Size |
|---|---|
| Chesney_TVECIpi_JCO_2017 |
981.11 KB |
| ILI_Melphalan_TNFa_JCO_2005 |
398.84 KB |
| Miura_ILI_Melanoma_ASO_2019 |
1.3 MB |
| TVEC_Melanoma_JCO_2015 |
408.25 KB |
